|
|
Volumn 12, Issue SUPPL. 4, 2006, Pages 1-2
|
|
Pharmacokinetic studies in patients with inherited bleeding disorders - Challenges and relevance to clinical practice
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BLOOD CLOTTING FACTOR 8 ANTIBODY;
RECOMBINANT BLOOD CLOTTING FACTOR 13;
RECOMBINANT BLOOD CLOTTING FACTOR 7A;
RECOMBINANT BLOOD CLOTTING FACTOR 8;
RECOMBINANT BLOOD CLOTTING FACTOR 9;
RECOMBINANT PROTEIN;
UNCLASSIFIED DRUG;
ACCURACY;
BLEEDING DISORDER;
BLOOD CLOTTING FACTOR 13 DEFICIENCY;
BODY WEIGHT;
CLINICAL PRACTICE;
CONTROL;
COST EFFECTIVENESS ANALYSIS;
DRUG BLOOD LEVEL;
DRUG DOSE REGIMEN;
DRUG HALF LIFE;
DRUG MONITORING;
EDITORIAL;
HEMOPHILIA A;
HEMOSTASIS;
HUMAN;
IN VIVO STUDY;
LEAN BODY WEIGHT;
LIVER WEIGHT;
PRIORITY JOURNAL;
THROMBIN TIME;
TREATMENT OUTCOME;
VASCULAR ENDOTHELIUM;
|
|
EID: 33748792026
PISSN: 13518216
EISSN: 13652516
Source Type: Journal
DOI: 10.1111/j.1365-2516.2006.01325.x Document Type: Editorial |
|
Times cited : (2)
|
|
References (0)
|
